Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.21.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2021
Stock-Based Compensation [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following table provides the assumptions used to determine the grant date fair value of the market condition-dependent / TSR goal-based portion of the Company’s performance stock units granted during the three months ended March 31, 2021 using a Monte Carlo simulation:
Expected dividend yield —  %
Risk-free interest rate 0.20  %
Expected volatility 41.70  %
Expected term (in years) 2.95
Grant date fair value $ 13.21 
Schedule of Nonvested Restricted Stock and Performance Stock Unit Activity
The following table summarizes the activity for the Company’s restricted stock units and performance stock units for the three months ended March 31, 2021:
Restricted Stock Units Performance Stock Units
Number of
Units		 Weighted Average Grant Date Fair Value (per share) Number of
Units		 Weighted Average Grant Date Fair Value (per share)
Nonvested as of December 31, 2020 1,841,139  $ 16.14  965,736  $ 17.69 
Granted 1,697,623  $ 15.39  211,985  $ 13.21 
Vested (745,647) $ 16.06  —  $ — 
Forfeited (4,966) $ 16.11  (7,829) $ 12.24 
Nonvested as of March 31, 2021 2,788,149  $ 15.70  1,169,892  $ 16.92 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation expense for the Company is as follows:
Three months ended
March 31,
2021 2020
Continuing operations $ 6,305  $ 4,294 
Discontinued operations 1,875  1,626 
Stock-based compensation expense 8,180  5,920 
Continuing operations (1,543) (1,065)
Discontinued operations (459) (403)
Income tax benefit (2,002) (1,468)
Continuing operations 4,762  3,229 
Discontinued operations 1,416  1,223 
Stock-based compensation expense, net of income tax benefit $ 6,178  $ 4,452